Dow Up 0.76% Nasdaq Up 0.69%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.91 Down 0.06(6.69%) Oct 24, 3:57PM EDT
Prev Close:0.97
Open:0.98
Bid:N/A
Ask:N/A
1y Target Est:3.00
Beta:1.13
Next Earnings Date:N/A
Day's Range:0.90 - 1.02
52wk Range:0.47 - 2.67
Volume:441,864
Avg Vol (3m):388,855
Market Cap:84.56M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVIV

Comparison

Symbol% ChgMkt Cap
NVIVDown 6.69%84.56M
ACORDown 2.23%1.41B
ALSEUp 16.67%1.07M
STEMUp 1.29%80.65M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Invivo Therapeutics Holdings Corp., a development stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback